| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3924423 | European Urology | 2010 | 7 Pages |
Abstract
A novel adoptive immunotherapy based on T cells from tumor-draining lymph nodes is feasible in advanced UBC. Infusion of expanded, autologous, tumor-specific T-helper cells might be a future treatment option in metastasized UBC. Long-term overall survival remains to be determined.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Amir Sherif, Mudhar N. Hasan, Per Marits, Mona Karlsson, Ola Winqvist, Magnus Thörn,